Fundraising Fox
/Companies
Sign in

Corinnova

Houston, US · Texas corporation · 8 known investors

Find your way into Corinnova

Sign up to see every warm intro you have to Corinnova

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Corinnova team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

CorInnova develops a minimally invasive, non-blood contacting cardiac assist device designed to treat acute heart failure patients who cannot use existing solutions. The collapsible device is delivered via minimally invasive procedures and compresses the heart externally to increase cardiac output without the risks of blood clotting, stroke, or anticoagulation-related complications.

Deep TechHealthtechMedical Devices

Founders & leadership

JCJohn Criscione
John CriscioneFounder
WAWilliam Altman
William AltmanChief Executive Officer, Cardiac Medical Device Company
DR
Dennis RobinsNamed on SEC filing
BL
Boris LeschinskyNamed on SEC filing
CM
Clarice MotterNamed on SEC filing
KS
Keith SvagerkoNamed on SEC filing
MT
Michael TinerNamed on SEC filing

Board

GLGeorge Letsou
George LetsouSenior Surgical Advisor

Investors · 8

Houston Angel Network✓ confirmed by CorinnovaHouston

How we know: the company's own site · Not right? Tell us

Keiretsu Forum✓ confirmed by CorinnovaSan Francisco East Bay · $250K – $2M

How we know: the company's own site · Keiretsu Forum's portfolio page · Not right? Tell us

TMC Venture Fund✓ confirmed by CorinnovaHouston

How we know: TMC Venture Fund's portfolio page · the company's own site · Not right? Tell us

Harvard Business School Alumni Angels of Greater New York✓ confirmed by CorinnovaNew York

How we know: the company's own site · Not right? Tell us

Wellcome Trust✓ confirmed by CorinnovaLondon

How we know: the company's own site · Not right? Tell us

Aggie Angel Networklisted by Aggie Angel NetworkCollege Station
Frontera Technology Ventureslisted by Frontera Technology VenturesTexas

Reported raises · per SEC filings

Form D private placements

$350K disclosed across 1 round · 2017

▶$350KraisedJul 2017 · 3 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • John CriscioneDirector
  • Dennis RobinsDirector
  • Boris LeschinskyExecutive Officer
  • Clarice MotterExecutive Officer
  • Keith SvagerkoExecutive Officer
  • William AltmanExecutive Officer, Director
  • Michael TinerDirector
Offering amount
$8.8M
Amount sold
$350K
Minimum investment
$25K
Proceeds to insiders
$1.3M
First sale
Jun 2017
Incorporated
Corporation, Texas
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 5

Rf SurgicalMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
CorwaveCorWave produces a ventricular assist pump for advanced heart failure patients, delivering pulsatile flow to provide mechanical cardiac support for transplant candidates, non-transplant-eligible patients, and recovery cases.
ToperaAbbott's Lingo Glucose System is a continuous glucose monitoring device for non-insulin users aged 18+, designed to track glucose levels and support metabolic health decisions.
Ancora HeartAncora Heart develops minimally invasive medical devices, including a class III implantable therapy for cardiovascular treatment. The company focuses on cardiac/heart failure therapy development, clinical research, and commercialization of its core technology.
BioworldBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.

Companies working in the same space as Corinnova.

Frequently asked questions

What does Corinnova do?
CorInnova develops a minimally invasive, non-blood contacting cardiac assist device designed to treat acute heart failure patients who cannot use existing solutions. The collapsible device is delivered via minimally invasive procedures and compresses the heart externally to increase cardiac output without the risks of blood clotting, stroke, or anticoagulation-related complications.
Who founded Corinnova?
Corinnova was founded by John Criscione.
Who are Corinnova's investors?
Corinnova's investors include Cowtown Angels, Houston Angel Network, Keiretsu Forum, TMC Venture Fund, Harvard Business School Alumni Angels of Greater New York, Wellcome Trust, Aggie Angel Network, Frontera Technology Ventures.
How much funding has Corinnova raised?
Corinnova has disclosed $350K raised across 1 round.
Where is Corinnova headquartered?
Corinnova is headquartered in Houston, US.